Glycobiology Market - Growth, Trends, and Forecast (2020 - 2025)
|出版商||Mordor Intelligence LLP||商品編碼||661003|
|出版日期||內容資訊||英文 120 Pages
|醣生物學的全球市場:各產品類型、應用、終端用戶、地理的成長率，趨勢及預測(2018年∼2023年) Glycobiology Market - Growth, Trends, and Forecast (2020 - 2025)|
|出版日期: 2020年02月01日||內容資訊: 英文 120 Pages||
The glycobiology market will show rapid growth due to the increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies.
Drug Discovery and Development is Expected to be the Largest Growing Segment
On the basis of application, drug discovery and development has been accounted for the largest market share. This is primarily owing to extensive R&D and increased government funding for research related to glycomics and proteomics. There is an increasing R&D investments by pharmaceutical companies, which increases the drug discovery and development of glycomics. For instance, R&D expenditure of Merck accounted for USD 9.8 billion, in 2018.
The other applications segment is anticipated to witness the high CAGR due to rising clinical trials and R&D expenses incurred by key companies for research.
North America is Found Leading the Glycobiology Market
North America has been accounted for the largest market share due to the presence of key pharmaceutical and biopharmaceutical companies. The presence of well-established healthcare infrastructure and accessibility to advanced products have driven the regional market. Moreover, there is also increasing applications of glycans in various cancers and increasing funds from the government in enhancing the field of glycobioogy, that helps the market to grow over the forecast period.
There has been a presence of a considerable number of companies that are significantly contributing to the market growth. New product launches, mergers and acquisitions, partnerships, and collaborations are the key strategies undertaken by these companies for sustainable growth.